1. Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Curr Opin Ophthalmol. 2011 Jul;22(4):279-82.
2. Fariselli C, et al. Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markets and mucin expression in dry eye patients. Clinical Ophthalmology; 2018 (12): 1293- 1300.
3. Dry Eye Workshop (DEWS) Committee. 2007 Report of the Dry Eye Workshop (DEWS). Ocul Surf. April 2007;5(2):65-204.
4. IMS IQVIA Dataview: 08/2021.
5. Baudoin et al. Trehalose: an intriguing disaccharide with potential for medical application in ophtalmology. Clinical Ophtalmology. 2011;5:577-81.
6. Baudouin C, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013; 11.
7. Li J et al. Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system. Molecular Vision 2012; 18:317-329.
8. Chen W, Zhang X, Lin M, Zhang J, Ye Y, Lin Y, Luyckx J. Trehalose protects against ocular surface disorders in Experimental murine dry eye through suppression of apoptosis. Experimental Eye Research 2009; Vol.89, 311-318.
9. Nakamura M et al. Characterisation of water retentative properties of hyaluronan. Cornea 1993;12(6):433-6.
10. Snibson et al. Ocular Surface Residence Times of Artificial Tears Solutions. Cornea 1998;11(4):288- 293.
11. McCann LC et al. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea 2012;31(1):1-6.